INSULET CORP
Develops tubeless, automated insulin delivery systems for people with diabetes.
PODD | NDAQ
Overview
Corporate Details
- ISIN(s):
- US45784P1012
- LEI:
- Country:
- United States of America
- Address:
- 100 NAGOG PARK, 1720 ACTON
- Website:
- https://www.omnipod.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Insulet Corporation is an innovative medical device company focused on simplifying life for individuals with insulin-dependent diabetes. The company develops, manufactures, and markets the Omnipod® platform, a line of tubeless, wearable insulin management systems. Its key products include the Omnipod DASH® System and the Omnipod® 5 Automated Insulin Delivery System. The Omnipod 5 is a hybrid closed-loop system that integrates with compatible continuous glucose monitors (CGMs) and uses its proprietary SmartAdjust™ technology to automatically adjust insulin delivery. This system is designed to provide continuous subcutaneous insulin infusion for individuals with type 1 and type 2 diabetes, offering an alternative to traditional tubed pumps and multiple daily injections.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all INSULET CORP filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for INSULET CORP
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for INSULET CORP via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
